Title | Changes in US Clinician Waivers to Prescribe Buprenorphine Management for Opioid Use Disorder During the COVID-19 Pandemic and After Relaxation of Training Requirements. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Spetz, J, Hailer, L, Gay, C, Tierney, M, Schmidt, L, Phoenix, B, Chapman, S |
Journal | JAMA Netw Open |
Volume | 5 |
Issue | 5 |
Pagination | e225996 |
Date Published | 2022 May 02 |
ISSN | 2574-3805 |
Keywords | Buprenorphine, COVID-19, Humans, Opiate Substitution Treatment, Opioid-Related Disorders, Pandemics |
Abstract | This case series examines numbers of US clinicians receiving waivers from the Drug Enforcement Administration allowing them to prescribe buprenorphine for opioid use disorder before and during the COVID-19 pandemic. |
DOI | 10.1001/jamanetworkopen.2022.5996 |
Alternate Journal | JAMA Netw Open |
PubMed ID | 35552728 |
PubMed Central ID | PMC9099425 |
Grant List | R01 DA047379 / DA / NIDA NIH HHS / United States |